Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07633002Not yet recruiting
Randomised, open-label trial of human chorionic gonadotropin in infertility (2 arms), sponsored by Second Hospital of Shandong University. Primary endpoint: Live birth at 28 weeks. Planned start Jul 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07633002.